What is the perioperative management of hormone replacement therapy (HRT)?

Updated: Jan 09, 2018
  • Author: Nafisa K Kuwajerwala, MD; Chief Editor: William A Schwer, MD  more...
  • Print


Hormone replacement therapy (HRT) in postmenopausal women may increase the risk of postoperative venous thromboembolism. A similar controversy exists as with OCPs. Most women on HRT are likely to have additional risk factors for thromboembolism because of their age; hence, perioperative thromboprophylaxis is prudent, rather than subjecting the patient to the risk of provoking postmenopausal symptoms by stopping HRT.

In the event of an emergency surgery in patients on combined OCPs or HRT, perioperative thromboprophylaxis is warranted.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!